Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 249

The DOI matches its Crossref record.

Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer

Open access
Mieog, J. Sven D., Troyan, Susan L., Hutteman, Merlijn, Donohoe, Kevin J., van der Vorst, Joost R., Stockdale, Alan, Liefers, Gerrit-Jan, Choi, Hak Soo, Gibbs-Strauss, Summer L., Putter, Hein, Gioux, Sylvain, Kuppen, Peter J. K., Ashitate, Yoshitomo, Löwik, Clemens W. G. M., Smit, Vincent T. H. B. M., Oketokoun, Rafiou, Ngo, Long H., van de Velde, Cornelis J. H., Frangioni, John V., Vahrmeijer, Alexander L.·2011·Annals of Surgical Oncology

Abstract

BACKGROUND: Near-infrared (NIR) fluorescent sentinel lymph node (SLN) mapping in breast cancer requires optimized imaging systems and lymphatic tracers. MATERIALS AND METHODS: A small, portable version of the FLARE imaging system, termed Mini-FLARE, was developed for capturing color video and two semi-independent channels of NIR fluorescence (700 and 800 nm) in real time. Initial optimization of lymphatic tracer dose was performed using 35-kg Yorkshire pigs and a 6-patient pilot clinical trial. More refined optimization was performed in 24 consecutive breast cancer patients. All patients received the standard of care using (99m)Technetium-nanocolloid and patent blue. In addition, 1.6 ml of indocyanine green adsorbed to human serum albumin (ICG:HSA) was injected directly after patent blue at the same location. Patients were allocated to 1 of 8 escalating ICG:HSA concentration groups from 50 to 1000 μM. RESULTS: The Mini-FLARE system was positioned easily in the operating room and could be used up to 13 in. from the patient. Mini-FLARE enabled visualization of lymphatic channels and SLNs in all patients. A total of 35 SLNs (mean = 1.45, range 1-3) were detected: 35 radioactive (100%), 30 blue (86%), and 35 NIR fluorescent (100%). Contrast agent quenching at the injection site and dilution within lymphatic channels were major contributors to signal strength of the SLN. Optimal injection dose of ICG:HSA ranged between 400 and 800 μM. No adverse reactions were observed. CONCLUSIONS: We describe the clinical translation of a new NIR fluorescence imaging system and define the optimal ICG:HSA dose range for SLN mapping in breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1245/s10434-011-1566-x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 249

Metadata

Authors
Mieog, J. S. D., Troyan, S. L., Hutteman, M., Donohoe, K. J., van der Vorst, J. R., Stockdale, A., Liefers, G.-J., Choi, H. S., Gibbs-Strauss, S. L., Putter, H., Gioux, S., Kuppen, P. J. K., Ashitate, Y., Löwik, C. W. G. M., Smit, V. T. H. B. M., Oketokoun, R., Ngo, L. H., van de Velde, C. J. H., Frangioni, J. V., & Vahrmeijer, A. L.
Venue
Annals of Surgical Oncology
Published
2011-03-01
Volume
18
Issue
9
Pages
2483-2491
ISSN
  • 1068-9265 (ISSN-L)
  • 1534-4681
OpenAlex
W2147220302
Cited by
249
References
0
FWCI
19.99
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer. https://app.cochat.ai/papers/10.1245/s10434-011-1566-x
The paper
Mieog, J. S. D., Troyan, S. L., Hutteman, M., Donohoe, K. J., van der Vorst, J. R., Stockdale, A., Liefers, G.-J., Choi, H. S., Gibbs-Strauss, S. L., Putter, H., Gioux, S., Kuppen, P. J. K., Ashitate, Y., Löwik, C. W. G. M., Smit, V. T. H. B. M., Oketokoun, R., Ngo, L. H., van de Velde, C. J. H., Frangioni, J. V., & Vahrmeijer, A. L. (2011). Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-011-1566-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.